A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges

Journal of Clinical Psychiatry

Volumn 69, Issue 5, 2008, Pages 783-789

  Grant, Jon E ^a   Suck, Won Kim ^a   Hartman, Boyd K ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALTREXONE; ONDANSETRON; PLACEBO;

ADULT; ANXIETY; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GAMBLING SYMPTOM ASSESSMENT SCALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATHOLOGICAL GAMBLING; PATHOLOGICAL GAMBLING ADAPTATION OF THE YALE BROWN OBSESSIVE COMPULSIVE SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SOCIAL PSYCHOLOGY; TREATMENT RESPONSE; XEROSTOMIA;

EID: 45249097353     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0511     Document Type: Article

References (38)

1. Blaszczynski A, McConaghy N, Frankova A. Crime, antisocial personality, and pathological gambling. J Gambl Behav 1989;5(2):137-152
2. National Opinion Research Center. Gambling Impact and Behavior Study. Chicago, Ill: University of Chicago; 1999
3. Potenza MN, Steinberg MA, McLaughlin SD, et al. Illegal behaviors in problem gambling: analysis of data from a gambling helpline. J Am Acad Psychiatry Law 2000;28(4):389-403
4. Grant JE, Kim SW. Demographic and clinical features of 131 adult pathological gamblers. J Clin Psychiatry 2001;62(12):957-962
5. Petry NM, Kiluk BD. Suicidal ideation and suicide attempts in treatment-seeking pathological gamblers. J Nerv Ment Dis 2002;190(7):462-469
6. Cunningham-Williams RM, Cottler LB, Compton WM III, et al. Taking chances: problem gamblers and mental health disorders - results from the St. Louis Epidemiologic Catchment Area study. Am J Public Health 1998;88(7):1093-1096
7. Shaffer HJ, Hall MN, Vander Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health 1999;89(9):1369-1376
8. Pasternak AV, Fleming MF. Prevalence of gambling disorders in a primary care setting. Arch Fam Med 1999;8(6):515-520
9. Grant JE, Levine L, Kim D, et al. Prevalence of impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 2005;162:2184-2188
10. Potenza MN, Levinson-Miller C, Poling J, et al. Gambling risk behaviors in alcohol dependent individuals with co-occurring disorders. Alcohol Clin Exp Res 2005;28:115A
11. Grant JE, Potenza MN. Escitalopram in the treatment of pathological gambling with co-occurring anxiety: an open-label study with double-blind discontinuation. Int Clin Psychopharmacol 2006;21(4):203-209
12. Martin WR, Jasinski D, Mansky P. Naltrexone, an antagonist for the treatment of heroin dependence: effects in man. Arch Gen Psychiatry 1973;28(6):784-791
13. Volpicelli JR, Alterman AI, Hayashida M, et al. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992;49(11):876-880
14. Anton RF, Moak DH, Waid LR, et al. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 1999;156(11):1758-1764
15. Kim SW, Grant JE. An open naltrexone treatment study in pathological gambling disorder. Int Clin Psychopharmacol 2001;16(5):285-289
16. Kim SW, Grant JE, Adson D, et al. Preliminary report on a possible naltrexone and nonsteroidal analgesic interaction [letter]. J Clin Psychopharmacol 2001;21(6):632-634
17. Kim SW, Grant JE, Adson DE, et al. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001;49(11):914-921
18. Matthews RT, German DC. Electrophysiological evidence for excitation of rat ventral tegmental area and dopamine neurons by morphine. Neuroscience 1984;11(3):617-625
19. Stewart J. Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol Biochem Behav 1984;20(6):917-923
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
21. Grant JE, Steinberg MA, Kim SW, et al. Preliminary validity and reliability testing of a structured clinical interview for pathological gambling (SCI-PG). Psychiatry Res 2004;128(1):79-88
22. Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987;144(9):1184-1188
23. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-Patient Edition (SCID-I/P, Version 2.0). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1995
24. Pallanti S, DeCaria CM, Grant JE, et al. Reliability and validity of the Pathological Gambling Adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). J Gambl Stud 2005;21(4):431-443
25. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32(1):50-55
26. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23(2):56-62
27. Sheehan DV. The Anxiety Disease. New York, NY: Scribner; 1983
28. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
29. Davison AC, Hinkley DV. Bootstrap Methods and Their Application. Cambridge, United Kingdom: Cambridge University Press; 1997
30. Kim SW. Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry 1998;59(4):159-164
31. Kosten TR, Kleber HD, Morgan C. Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci 1989;44(13):887-892
32. Mason BJ, Salvato FR, Williams LD, et al. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry 1999;56(8):719-724
33. Broekkamp CL, Phillips AG. Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area. Pharmacol Biochem Behav 1979;11(3):289-295
34. Anton RF, O'Malley SS, Ciraulo CC, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006;295(17):2003-2017
35. Grant JE, Potenza MN. Treatments for pathological gambling and other impulse control disorders. In: Nathan PE, Gorman JM, eds. A Guide to Treatments That Work. 3rd ed. New York, NY: Oxford University Press; 2007:561-577
36. Hodgins DC, Petry NM. Cognitive and behavioral treatments. In: Grant JE, Potenza MN, eds. Pathological Gambling: A Clinical Guide to Treatment. Washington, DC: APPI; 2004:169-187
37. Hodgins DC, Peden N. Cognitive-behavioral treatment for impulse control disorders [published online ahead of print Aug 3, 2007]. Rev Bras Psiquiatr. doi: 10.1590/51516-44462006005000055
38. Petry NM, Ammerman Y, Bohl J, et al. Cognitive-behavioral therapy for pathological gamblers. J Consult Clin Psychol 2006;74(3):555-567